These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24396653)

  • 41. A clinical guide to the management of Graves' disease with radioactive iodine.
    Levetan C; Wartofsky L
    Endocr Pract; 1995; 1(3):205-12. PubMed ID: 15251595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health-Related Quality of Life (HRQoL) of Adult Filipinos with Graves' Disease cured by Radioiodine Therapy compared to those controlled by Antithyroid Drugs at University of Santo Tomas Hospital: A Pilot Study.
    Mangelen SF; Cunanan E
    J ASEAN Fed Endocr Soc; 2017; 32(2):100-107. PubMed ID: 33442092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
    Hu RT; Liu DS; Li B
    BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chylothorax Associated with Substernal Goiter in Graves' Disease Treated with Radioactive Iodine.
    Young Oh S; Hyun Kim B; Young Kim D; Min Lee K; Jin Lee M; Su Kim S; Ho Kim J; Kyung Jeon Y; Soo Kim S; Ki Kim Y; Joo Kim I
    Int J Endocrinol Metab; 2017 Apr; 15(2):e41787. PubMed ID: 28835765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graves' ophthalmopathy: the case for thyroid surgery.
    Lowery AJ; Kerin MJ
    Surgeon; 2009 Oct; 7(5):290-6. PubMed ID: 19848063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
    Vannucchi G; Covelli D; Campi I; Currò N; Dazzi D; Rodari M; Pepe G; Chiti A; Guastella C; Lazzaroni E; Salvi M
    Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407
    [No Abstract]   [Full Text] [Related]  

  • 47. An Unusual Case of Metastatic Functional Thyroid Carcinoma With a Remarkable Treatment Response to Radioactive Iodine.
    Geliebter A; Brutsaert EF; Surks MI
    J Endocr Soc; 2017 Dec; 1(12):1440-1444. PubMed ID: 29264468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves' Disease in Ethiopia.
    Mengistu HS; Getahun KT; Alemayehu L; Gezahign S
    Clinicoecon Outcomes Res; 2022; 14():221-229. PubMed ID: 35431562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.
    Gibson A; Dave A; Johnson C; Kotwal A; Fingeret AL
    J Surg Res; 2020 Dec; 256():486-491. PubMed ID: 32798996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total thyroidectomy for Graves' disease.
    Razack MS; Lore JM; Lippes HA; Schaefer DP; Rassael H
    Head Neck; 1997 Aug; 19(5):378-83. PubMed ID: 9243264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioiodine I-131 for the therapy of graves' disease.
    Mumtaz M; Lin LS; Hui KC; Mohd Khir AS
    Malays J Med Sci; 2009 Jan; 16(1):25-33. PubMed ID: 22589645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status.
    Davies TF; Platzer M; Farid NR
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):183-91. PubMed ID: 6121637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful Management of Patients with Co-existent Graves' Disease and Autoimmune Hepatitis.
    Rana S; Ahmed Z; Salgia R; Bhan A
    Cureus; 2019 May; 11(5):e4647. PubMed ID: 31312572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease.
    Cury AN; Meira VT; Monte O; Marone M; Scalissi NM; Kochi C; Calliari LE; Longui CA
    Endocr Connect; 2013 Mar; 2(1):32-7. PubMed ID: 23781316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical treatment of Graves' disease: evidence-based approach.
    Stålberg P; Svensson A; Hessman O; Akerström G; Hellman P
    World J Surg; 2008 Jul; 32(7):1269-77. PubMed ID: 18327526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
    Mishra A; Mishra SK
    J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histologic Findings and Cytological Alterations in Thyroid Nodules After Radioactive Iodine Treatment for Graves' Disease: A Diagnostic Dilemma.
    El Hussein S; Omarzai Y
    Int J Surg Pathol; 2017 Jun; 25(4):314-318. PubMed ID: 28201927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment.
    Lu L; Gao C; Zhang N
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):303-309. PubMed ID: 32734611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW; Lee J; Bae JH; Seo JH; Kang SM; Ahn BC; Lee I
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaplastic thyroid carcinoma associated with Graves' disease.
    Majima T; Komatsu Y; Doi K; Shigemoto M; Takagi C; Fukao A; Kojima M; Tamaki H; Ito J; Nakao K
    Endocr J; 2005 Oct; 52(5):551-7. PubMed ID: 16284432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.